During a busy period of overhaul at Sanofi, the company is restructuring its U.S. vaccine commercial group.The company is 'implementing a streamlined strategic sales structure' as the U.S. vaccine market continues to evolve, a spokesperson said. The move is 'aimed at optimizing our commercial structure for greater efficiency and effectiveness,' he added.'As with any change in our organization, we are providing multiple avenues of support to impacted employees, including both financial support, and outplacement assistance, as well as the opportunities to apply for the new positions,' Sanofi's spokesperson said.Endpoints News first reported the development on Thursday.Word of the unit's restructuring comes shortly after Fierce Biotech revealed details of an ongoing R&D overhaul at the company.

在赛诺菲繁忙的大修期间，该公司正在重组其美国分公司。S、 疫苗商业集团。一位发言人说，随着美国疫苗市场的不断发展，该公司正在“实施精简的战略销售结构”。他补充说，此举旨在优化我们的商业结构，提高效率和效益赛诺菲发言人说，与公司的任何变革一样，我们正在为受影响的员工提供多种支持途径，包括财务支持和再就业援助，以及申请新职位的机会。Endpoints News于周四首次报道了这一进展。在激烈的生物技术公司披露了该公司正在进行的研发大修细节后不久，该部门重组的消息传出。

In an email to Sanofi staffers earlier this month, Sanofi's head of R&D, Houman Ashrafian, Ph.D., explained that the company would be adopting “a simplified R&D structure,' Fierce Biotech reported. Layoffs are expected as a result of the pipeline transition.RelatedJPM23: Sanofi has reached the 'steady state' Paul Hudson envisioned years ago, CEO saysBesides that revelation, Sanofi recently said it'd be selling a site in San Francisco that the drugmaker picked up from its $1 billion buyout of Amunix Pharmaceuticals.

在本月早些时候发给赛诺菲员工的一封电子邮件中，赛诺菲研发主管霍曼·阿什拉菲安博士解释说，该公司将采用“简化的研发结构”，激烈的生物技术报道。裁员预计是由于管道过渡。相关JPM23：赛诺菲已经达到了多年前保罗·哈德森设想的“稳定状态”，首席执行官表示，赛诺菲最近表示，将在旧金山出售一个网站，该网站是该制药商从其10亿美元收购Amunix Pharmaceuticals中获得的。

The company recently disclosed 100 layoffs in California at the Amunix headquarters.Several weeks before that, Sanofi disclosed layoff plans at a U.K. site acquired in its 2021 buyout of Kymab.RelatedSanofi CEO Paul Hudson's new 'Play to Win' pivot sends stock plunging  Sanofi has been working toward CEO Paul Hudson's 'play to win' strategy since shortly after he joined the company in 2019.

该公司最近披露在加利福尼亚州阿穆尼克斯总部裁员100人。几周前，赛诺菲披露了2021年收购Kymab时收购的英国工厂的裁员计划。相关赛诺菲首席执行官保罗·哈德逊（PaulHudson）的新“赢球”支点导致股价暴跌，自2019年加入赛诺菲首席执行官保罗·哈德逊（PaulHudson）不久以来，赛诺菲一直致力于实现其“赢球”战略。

But, after a recent strategy refresh in October, Sanofi's stock price fell sharply.

但是，在最近10月份重新调整战略后，赛诺菲的股价急剧下跌。